Source: Health Products Regulatory Authority (ZA) Revision Year: 2021 Publisher: RANBAXY PHARMACEUTICALS (PTY) LTD, 14 Lautre Road, Stormill, Ext. 1, Roodepoort, 1724, South Africa
RAZTROL (Tablets 10 mg).
| Pharmaceutical Form |
|---|
|
Tablet. RAZTROL is a salmon coloured, 6,35 mm ± 0.1 mm round, biconvex, uncoated tablets, plain on both sides. |
Each tablet contains: Rupatadine fumarate 12,79 mg equivalent to rupatadine 10 mg.
For full list of excipients, see section 6.1.
Contains sugar: lactose monohydrate 60 mg per tablet.
| Active Ingredient | Description | |
|---|---|---|
| Rupatadine |
Rupatadine is a second-generation antihistamine, long-acting histamine antagonist, with selective peripheral H1-receptor antagonist activity. Some of the metabolites (desloratadine and its hydroxylated metabolites) retain an antihistaminic activity and may partially contribute to the overall efficacy of the drug. |
| List of Excipients |
|---|
|
Iron oxide red |
RAZTROL tablets are packed in blister packs consisting of PVC/PVDC foil as a forming material and pre-printed aluminium foil as a lidding material. Each blister will contain 10 tablets. Blisters are packed in a carton in pack sizes of 10, 20 or 30 tablets.
RANBAXY PHARMACEUTICALS (PTY) LTD, 14 Lautre Road, Stormill, Ext. 1, Roodepoort, 1724, South Africa
55/5.7.1/0293
7 December 2021
| Drug | Countries | |
|---|---|---|
| RAZTROL | South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
